Decitabine active in chronic myeloid leukaemia

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1406, 2003-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on chronic myeloid leukaemia

By Stark Gail O'Brien Stephen G

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 354-357

Royal College Of Physicians

Access to resources Recommend Favorite

Decitabine: First report of differentiation syndrome in an elderly patient with acute myeloid leukaemia: case report

Reactions Weekly, Vol. 1, Iss. 1040, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Mitoxantrone: Chronic myeloid leukaemia: case report

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

AraC-based pharmacotherapy of chronic myeloid leukaemia

By Reiter Andreas Hochhaus Andreas Berger Ute Kuhn Christian Hehlmann Rüdiger

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1129-1135

Informa Healthcare

Access to resources Recommend Favorite

Imatinib mesylate in the treatment of chronic myeloid leukaemia

By Druker Brian J

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 963-971

Informa Healthcare

Access to resources Recommend Favorite